Clinical Trials Logo

Anesthesia clinical trials

View clinical trials related to Anesthesia.

Filter by:

NCT ID: NCT02048475 Withdrawn - Anesthesia Clinical Trials

Electroencephalogram During Desflurane Anaesthesia

Start date: January 2010
Phase: Phase 4
Study type: Interventional

To study the behavior of EEG during changing desflurane concentrations.

NCT ID: NCT01969903 Withdrawn - Anesthesia Clinical Trials

Study of Use of Dexmedetomidine for Regional Anesthesia

Start date: November 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to find out the proper amount of a drug called dexmedetomidine added to the local anesthetic drug called lidocaine to prolong the time and effect of pain relief provided for surgery. Dexmedetomidine (trade name Precedex) is approved by U.S. Food and Drug Administration (FDA) and indicated for sedation (calming effect). It has both pain relieving and calming effects when added to lidocaine. In the past, addition of higher amounts of dexmedetomidine to lidocaine decreased blood pressure and heart rate. The investigators plan to study the effect of lower amounts of dexmedetomidine to achieve the same level and duration of pain relief without reduction of blood pressure and heart rate.

NCT ID: NCT01716078 Withdrawn - Anesthesia Clinical Trials

The Effect of Brachial Plexus Nerve Block on Distal Peripheral Nerve Conduction

Start date: November 2011
Phase: N/A
Study type: Observational

The purpose of this study is to determine the conducting ability of distal extremity nerves after a supraclavicular brachial plexus nerve block (with local anesthetic) has been placed at a more proximal location in the upper extremity.

NCT ID: NCT01605929 Withdrawn - Anesthesia Clinical Trials

Clinical Evaluation of the Ultrasound-Guided Retroclavicular Brachial Plexus Block

Start date: July 2012
Phase: N/A
Study type: Interventional

The primary objective of this prospective, descriptive study is to evaluate the success rate of the retroclavicular brachial plexus block and catheter placement in 60 adult patients undergoing hand, wrist, or forearm surgery. The investigators will also evaluate any difficulties performing the procedure, the onset time and distribution of the block, incidence of adverse events, and patient's acceptance of the block.

NCT ID: NCT01233219 Withdrawn - Surgery Clinical Trials

Association Between Clinical Effect of Continuous Morphine Administration After Surgery and Pharmacogenetics

Start date: November 2010
Phase: N/A
Study type: Observational

Identification of the genetic polymorphisms that could be correlated either with a better clinical response or with a major predisposition of patients to develop tolerance and/or side effects to the treatment with morphine.

NCT ID: NCT01179932 Withdrawn - Anesthesia Clinical Trials

Anesthesia Charting Fidelity Study

Start date: August 2010
Phase:
Study type: Observational

Primary Objective: Conduct a prospective, observational pilot study that assesses the frequency and severity of anesthesia charting fidelity weaknesses in three separate clinical environments (Cardiac surgical operating room, cardiac surgical intensive care unit, and electrophysiology laboratory) as assessed by a customized error scoring system that focuses on the magnitude of errors among multiple continuous, categorical and dichotomous variables. The errors are being assessed in order to identify the most common charting inaccuracies so that target areas appropriate for testing of improvement strategies may be isolated.

NCT ID: NCT00670696 Withdrawn - Healthy Clinical Trials

A Study to Compare the Efficacy of Rapydan Versus Tetracaine Gel

Start date: April 2008
Phase: Phase 4
Study type: Interventional

Tetracaine gel 4% is a topical anaesthetic gel commonly used in the UK that contains 40 mg of tetracaine base per gram. Adequate anaesthesia can usually be achieved following a 30 minute application time for venopuncture and a 45 minute application time for venous cannulation. The hypothesis is that Rapydan medicated plaster is more effective than tetracaine gel in preventing venous cannulation related pain when applied for the recommended treatment durations of 30 minutes and 45 minutes respectively.